Compounds > 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline
Page last updated: 2024-08-23

2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and Idiopathic Parkinson Disease

2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline has been researched along with Idiopathic Parkinson Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moser, A; Qadri, F; Thümen, A1
Bamberg, H; Böhme, V; Moser, A; Nobbe, F; Scholz, J; Vieregge, P1
Dostert, P; Nagatsu, T; Naoi, M; Niwa, T; Takeda, N; Tatematsu, A; Yoshida, M; Yoshizumi, H2
Kajita, M; Nagatsu, T; Niwa, T; Takeda, N; Tatematsu, A; Watanabe, K; Yoshizumi, H1
Kömpf, D; Moser, A1

Other Studies

6 other study(ies) available for 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and Idiopathic Parkinson Disease

ArticleYear
Modulation of striatal serotonin and opioid receptor mRNA expression following systemic N-methyl-norsalsolinol administration.
    Journal of the neurological sciences, 2003, Dec-15, Volume: 216, Issue:1

    Topics: Animals; Antiparkinson Agents; Disease Models, Animal; Gene Expression; Levodopa; Male; Neostriatum; Parkinson Disease; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Opioid, delta; Receptors, Opioid, mu; RNA, Messenger; Serotonin; Tetrahydroisoquinolines; Up-Regulation

2003
Presence of N-methyl-norsalsolinol in the CSF: correlations with dopamine metabolites of patients with Parkinson's disease.
    Journal of the neurological sciences, 1995, Volume: 131, Issue:2

    Topics: Adult; Aged; Cerebrospinal Fluid Proteins; Dopamine; Female; Homovanillic Acid; Humans; Isoquinolines; Male; Middle Aged; Monoamine Oxidase; Parkinson Disease; Tetrahydroisoquinolines; Tyrosine

1995
Presence of tetrahydroisoquinoline-related compounds, possible MPTP-like neurotoxins, in parkinsonian brain.
    Advances in neurology, 1993, Volume: 60

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Biotransformation; Culture Techniques; Dopamine; Frontal Lobe; Gas Chromatography-Mass Spectrometry; Humans; Isoquinolines; Neurotoxins; Parkinson Disease; Structure-Activity Relationship; Tetrahydroisoquinolines

1993
Presence of N-methyldopamine in parkinsonian and normal human brains.
    Journal of chromatography, 1993, Mar-05, Volume: 613, Issue:1

    Topics: Brain; Deoxyepinephrine; Gas Chromatography-Mass Spectrometry; Humans; Isoquinolines; Parkinson Disease; Salsoline Alkaloids; Tetrahydroisoquinolines

1993
Presence of methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines, derivatives of the neurotoxin isoquinoline, in parkinsonian lumbar CSF.
    Life sciences, 1992, Volume: 50, Issue:24

    Topics: Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Electrochemistry; Female; Humans; Isoquinolines; Male; Middle Aged; Monoamine Oxidase; Parkinson Disease; Spinal Puncture; Tetrahydroisoquinolines

1992
Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brains.
    Biochemical and biophysical research communications, 1991, Jun-14, Volume: 177, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Aged, 80 and over; Biogenic Amines; Brain Chemistry; Female; Gas Chromatography-Mass Spectrometry; Humans; Isoquinolines; Male; Parkinson Disease; Tetrahydroisoquinolines

1991